ECOR Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ECOR shares is 29, representing 16.11% of the company's common stock.

ROYAL BANK OF CANADA, in the last quarter, reduced its stake in ECOR by -100% restricting it's holding to 0 shares of worth nearly -. SUSQUEHANNA INTERNATIONAL GROUP, LLP also lessened -100% of the ECOR shares from its portfolio, reducing its holding to 0 shares of worth -. TWO SIGMA ADVISERS, LP also shunned ECOR shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, N/A increased its stake in ECOR by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of ECOR to its portfolio, raising its holding to - shares of worth -. N/A also increased its ECOR shares holding by N/A which brought its holding to - shares worth -.

The insider with the most stakes in ECOR is Merck Global Health Innovation Fund, LLC , 10 percent owner at the company. Additionally, ECOR stock is highly held by director Errico Joseph P and director TULLIS JAMES L L among others.

Company executives, directors, and other insiders own 25.02% percent of electroCore, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which ECOR insiders have sold stock, totaling 0 shares. Insiders that have sold shares include POSNER BRIAN M and ERRICO JOSEPH P.

There have been 1 transaction(s) during the past 6-months in which electroCore, Inc. insiders have bought stock, totalling 5000 shares

Around 233.82K electroCore, Inc. shares are held by insiders, which represents about 25.02% of ECOR stock.

ECOR 10 percent owner, Merck Global Health Innovation Fund, LLC holds the largest portfolio of the company's shares. ECOR shares owned by Merck total nearly 3.35 million.

ROYAL BANK OF CANADA is the largest institutional owner in ECOR which holds 0 shares worth - or 0% of the total ECOR shares outstanding followed by SUSQUEHANNA INTERNATIONAL GROUP, LLP with ownership of 0 shares representing 0% of the ECOR ownership. TWO SIGMA ADVISERS, LP is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ECOR is concerned, it is a stock which is not optionable.

Number of ECOR shares short is 43.00K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 6.55M shares of ECOR are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ECOR has 4.45M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ECOR is 0.54.